Cyprus vs Netherlands: Cause of death, by non-communicable diseases, ages 0-4, male
Cyprus
40.2%
in 2021
Netherlands
39.4%
in 2021
Cyprus rank
45th
Netherlands rank
47th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Cyprus
- Netherlands
How they compare
Cyprus currently reports 40.2% against 39.4% in Netherlands, a difference of 0.8%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Netherlands ahead.
Cyprus ranks 45th and Netherlands ranks 47th of 185 countries.
Across the 3 decades both report, Cyprus averaged higher in 1 and Netherlands in 2.
Head to head by decade
| Decade | Cyprus | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.7% | 49.4% | 6.7% | Netherlands |
| 2010s | 36.4% | 44.1% | 7.7% | Netherlands |
| 2020s | 40.6% | 39.7% | 0.9% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Cyprus or Netherlands?
- Cyprus, at 40.2% against 39.4% in Netherlands as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Cyprus and Netherlands?
- 0.8%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Netherlands?
- 6 years are reported by both, from 2000 to 2021.
- How do Cyprus and Netherlands rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Cyprus ranks 45th and Netherlands ranks 47th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.